Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$2.2 - $4.2 $76.7 Million - $146 Million
-34,880,086 Reduced 75.8%
11,135,257 $23 Million
Q1 2022

May 13, 2022

SELL
$2.83 - $8.69 $86.5 Million - $266 Million
-30,579,856 Reduced 39.92%
46,015,343 $176 Million
Q4 2021

Feb 11, 2022

SELL
$8.31 - $14.92 $17.5 Million - $31.5 Million
-2,108,074 Reduced 2.68%
76,595,199 $565 Million
Q3 2021

Nov 12, 2021

BUY
$9.15 - $13.28 $720 Million - $1.05 Billion
78,703,273 New
78,703,273 $912 Million

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $9.25B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Senator Investment Group LP Portfolio

Follow Senator Investment Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Senator Investment Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Senator Investment Group LP with notifications on news.